We report a mutational and polymorphic analysis of the proteolipid protein
gene in members of 27 Japanese families with Pelizaeus-Merzbacher disease.
We found causative mutations in 6 members of 27 families (22.2%); 5 of the
6 mutations, including two novel mutations, Leu(45)Arg and 231 + 2T --> G,
resulted in the typically severe clinical symptoms. Paradoxically, the Cys(
219)Tyr mutation, presumed to disrupt the tertiary structure of proteolipid
protein by removing the disulfide bond between Cys(200) and Cys(219), was
associated with a mild clinical presentation wherein the patient could walk
with assistance and speak. It was inferred that the structural change prev
ented the toxicity associated with a gain of function mutation. Moreover, i
n one family 3 patients exhibited a intragenic polymorphism that did not se
gregate with the disease, suggesting a locus heterogeneity for Pelizaeus-Me
rzbacher disease.